CGON Competitors & Alternatives
Compare CG Oncology, Inc. Common stock with similar stocks in the same industry
Biotechnology
CGON
Main Stock$79.81
Tradestie Score
39
Market Cap
$3.01B
Revenue Growth
19.8%
Analyst Upside
+14.1%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$254.28
|
$8.30B | 17.3 | 55 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$76.84
|
$6.68B | - | 66 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$110.00
|
$6.64B | - | 49 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$114.95
|
$6.38B | - | 46 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$21.82
|
$6.03B | - | 39 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$59.50
|
$6.02B | - | 41 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$207.77
|
$5.92B | - | 66 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.27
|
$5.80B | 18.9 | 45 | Compare |
More CGON Analysis
Data updated: Aug 22, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry